Sermorelin + GHRP-2 Blend

Description

Sermorelin + GHRP-2 Overview

Sermorelin + GHRP-2 is a synthetic peptide combination investigated in endocrine and molecular research models for its potential interactions with growth hormone signaling pathways. This blend consists of two distinct investigational peptides.

Sermorelin is a 29-amino-acid fragment derived from the N-terminal region of growth hormone-releasing hormone (GHRH 1-29), commonly used in laboratory studies to examine GHRH receptor-mediated signaling. GHRP-2 is a synthetic hexapeptide belonging to the growth hormone secretagogue (GHS) class, studied for its interaction with GHS-R1a receptors in experimental models.

In research contexts, this combination is used to study coordinated receptor activation, intracellular endocrine signaling cascades, and pituitary hormone regulation within in vitro and preclinical experimental models.

Chemical and Molecular Properties

Property	Sermorelin	GHRP-2
Chemical Class	GHRH Analog Peptide	Growth Hormone Secretagogue Peptide
Molecular Formula	C149H246N44O42S	C45H55N9O6
Molecular Weight	3357.88 g/mol	817.99 g/mol
CAS Number	86168-78-7	158861-67-7
Peptide Length	29 amino acids	6 amino acids
Synonyms	Sermorelin, GHRH (1-29)	Pralmorelin, KP-102

Working Mechanism

Sermorelin Mechanism

Sermorelin functions as a ligand for the growth hormone-releasing hormone receptor (GHRH-R), a G-protein-coupled receptor (GPCR) located in pituitary-derived cellular models frequently used in endocrine research. The binding of Sermorelin to GHRH-R can initiate Gs protein-mediated signaling, which is associated with the activation of adenylyl cyclase and the subsequent elevation of cyclic adenosine monophosphate (cAMP) levels.

In in vitro cellular studies, increased cAMP concentrations may activate protein kinase A (PKA) pathways, leading to phosphorylation events that regulate transcriptional and signaling processes within endocrine cell models.

GHRP-2 Mechanism

GHRP-2 is investigated as an agonist of the growth hormone secretagogue receptor type 1a (GHS-R1a). This receptor is another G-protein-coupled receptor that is also known to interact with endogenous ghrelin signaling systems.

In experimental biochemical models, activation of GHS-R1a by peptide ligands can influence phospholipase C (PLC) signaling pathways, leading to inositol triphosphate (IP3) production, intracellular calcium mobilization, and downstream regulatory signaling events.

Combined Signaling Context

In research environments, the simultaneous presence of ligands targeting both GHRH-R and GHS-R1a allows investigators to explore:

• Parallel receptor signaling pathways
  
• Potential receptor cross-talk
  
• Integrated endocrine signaling networks
  
• Intracellular messenger regulation within pituitary-derived cell systems

These investigations focus on molecular communication between receptor pathways rather than organism-level outcomes.

Research Applications of the Product in Laboratory Settings

Receptor Binding and Activation Studies

In in vitro receptor assays, the peptides may be used to study ligand binding characteristics and receptor activation patterns involving GHRH receptors and GHS-R1a receptors. These studies help characterize receptor affinity, activation kinetics, and intracellular signaling responses.

Intracellular Signaling Research

Researchers employ peptide ligands in cell culture systems to evaluate downstream signaling events such as:

• cAMP-dependent signaling pathways
  
• Protein kinase activation cascades
  
• Calcium signaling and second messenger dynamics
  

These experiments contribute to the broader understanding of peptide-mediated GPCR signaling mechanisms.

Endocrine Pathway Modeling

In preclinical and experimental endocrine models, investigators may examine how multiple peptide ligands influence interconnected signaling pathways within pituitary-derived or engineered cellular systems.

Peptide Pharmacology and Structure-Function Studies

The peptides may also be utilized in structure-activity relationship (SAR) investigations examining how synthetic peptide fragments interact with GPCR receptor domains, providing insight into ligand recognition and receptor activation mechanisms.

These experimental approaches support fundamental research on peptide-based signaling molecules and endocrine regulatory networks within controlled laboratory environments.

Why Choose Purerawz for Sermorelin + GHRP-2?

Buy Sermorelin + GHRP-2 for laboratory research use from our online shop. At Purerawz, we provide high-quality reference materials. Each research compound comes with a Certificate of Analysis for verification of purity and concentration.

Disclaimer

This information is for educational purposes only and not medical advice. Products are for research use only. Research must follow IRB or IACUC guidelines. Verify information independently before purchasing. By ordering, you agree to our Terms and Conditions. If you are not 100% satisfied with the product you received, please contact us at support@purerawz.co

Reference Links

• Sinha, D. K., Balasubramanian, A., Tatem, A. J., Rivera-Mirabal, J., Yu, J., Kovac, J., Pastuszak, A. W., & Lipshultz, L. I. (2020). Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Translational Andrology and Urology, 9(S2), S149-S159. https://doi.org/10.21037/tau.2019.11.30
• Sigalos, J. T., Pastuszak, A. W., Allison, A., Ohlander, S. J., Herati, A., Lindgren, M. C., & Lipshultz, L. I. (2017). Growth hormone secretagogue treatment in hypogonadal men raises serum Insulin-Like growth Factor-1 levels. American Journal of Men S Health, 11(6), 1752-1757. https://doi.org/10.1177/1557988317718662